A Laboratory Strain of Leishmania major: Protective Effects on Experimental Leishmaniasis
- 22 Downloads
Leishmaniasis, as one of the most important vector-borne and zoonotic diseases, can be seen in different forms and is more prevalent in developing countries worldwide. Due to the absence of effective strategies in its prevention, treatment, and control, investigation of effective control strategies against the disease is necessary. In this research, we evaluated the immunogenicity of a cold-adapted laboratory strain of Leishmania major (LMC) in the mouse model.
Twenty BALB/c mice were divided into two groups. LMC group received 4 × 106 of LMC strain in 0.5 ml DMEM, and VLM group, as the control group, received 0.5 ml Dulbecco’s modified Eagle’s medium. Both groups were challenged with virulent L. major 3 weeks after inoculation.
The data obtained from the analysis of immune responses and histopathological changes interestingly revealed protection against L. major in immunized mice. Compared with the VLM group, the mice immunized with LMC strain of L. major in the LMC group showed a significant increase in IFN-γ and IgG2a levels (P < 0.05) which are important indexes for Th1-related immune responses. Additionally, significant differences in concentration of IgG1 and IgG total before and after the challenge was observed in LMC group (P < 0.05). Furthermore, the immunized mice showed a significant reduction in mean sizes of skin lesion and liver damage compared to the VLM group.
Based on the present findings on immunogenicity of LMC strain, it seems this strain is able to induce both humoral and cellular immunity and a significant protection against L. major in the mouse model.
KeywordsLeishmania major Cold-adapted laboratory strain Immunogenicity Histopathology BALB/c mice
This work was supported by the Research Council of Shiraz University and School of Veterinary Medicine, Shiraz University (94GCU5M83832) and the Razi Vaccine and Serum Research Institute, Shiraz Branch, Agricultural Research, Education and Extension Organization (AREEO).
Compliance with Ethical Standards
Conflict of Interest
The authors have no competing interests.
- 2.Asadi-Manesh R (2016) Histopathological and immunogenic study of Leishmania major LMC strain in inbred Balb/c mice. DVM Thesis. Shiraz University, IranGoogle Scholar
- 9.Cox FE (1996) The Wellcome Trust illustrated history of tropical diseases. Wellcome Trust, LondonGoogle Scholar
- 17.Hashemi-Fesharaki R, Ale-Agha S, Habibi G, Manhouri H, Esmail-Nia K, Mohammadi A (1998) Production of inactivated wet rural Leishmania major. Iran J Med Sci 23:74–80Google Scholar
- 28.Nadim A, Javadian E, Tahvildar-Bidruni G, Ghorbani M (1982) Effectiveness of leishmanization in the control of cutaneous leishmaniasis. Bull de la Société de Pathologie Exotique 76:377–383Google Scholar
- 31.Ramírez L, Santos DM, Souza AP, Coelho EA, Barral A, Alonso C et al (2013) Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis. Vaccine 31:1312–1319CrossRefGoogle Scholar
- 43.Zahedifard F, Gholami E, Taheri T, Taslimi Y, Doustdari F, Seyed N et al (2014) Enhanced protective efficacy of nonpathogenic recombinant Leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen. PLoS Negl Trop Dis 8:e2751CrossRefPubMedPubMedCentralGoogle Scholar